Navigating the ClinicalTrials.gov website

Researching and understanding clinical trial information can be daunting. With so many different sources of information and language that can be difficult to understand, trying to find a clinical trial that is right for you can be overwhelming. While ClinicalTrials.gov is the most comprehensive database for clinical trials, it is written for healthcare professionals and can be difficult to navigate. But don’t worry, there are several best practices that can help.

Nomenclature Change from NASH/NAFLD to MASH/MASLD

Non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) affect a high percentage of the global population, yet the terminology creates stigma and fails to encompass the main driver of liver injury—metabolic syndrome. After many years of debates, experts in the field have come up with new, more appropriate names for these conditions and introduced new terminology for patients who have both metabolic problems and consume alcohol.

COVID-19 Now: Accessing the Latest Vaccines

Regulatory authorities recommend that people get the latest COVID-19 booster, but for some the vaccines can be hard to find. Since the federal government stopped purchasing COVID-19 vaccines, there are fewer highly visible public vaccination sites and events than there were with the initial and earlier vaccines and boosters. Although the government is no longer purchasing COVID-19 vaccines, a new program has been announced to provide access for people without insurance at no cost to them. People with insurance still have access to COVID-19 vaccines with no out-of-pocket cost, but there may be fewer locations where they can get the vaccines.

Pancreatic Cancer: Overview and Promising New Therapies

Pancreatic cancer is rarely diagnosed before spreading to other organs. Thankfully, researchers are developing promising new therapies that can be used to treat it. The American Cancer Society predicts that about 64,050 people in the United States will be diagnosed with pancreatic cancer in 2023. This aggressive cancer, which accounts for about 7% of all cancer deaths, is slightly more common in men than women.

The importance of diversity in clinical studies

People of all ages, races and ethnicities—who are either healthy or have pre-existing conditions—participate in clinical trials research all over the world. You can too.

Global Regulatory Consulting Solutions

Making Clinical Trials Available to All

Clinical trials are an essential and fundamental component of bringing any new drug or treatment to market. The purpose of clinical trials is to measure the efficacy (meaning the ability to achieve an intended result) and safety (identifying, evaluating, and minimizing associated risks) of new treatments. Without patients on those trials, new drugs don't get developed. So, ensuring that these trials work for all – regardless of gender, ethnicity, age, or affordability – is a really important consideration the drug developers take when designing trials.

How diabetes drugs are used for weight loss

The rate of obesity worldwide has almost tripled since 1975, leading to a global epidemic of obesity and overweight. As of 2016, reportedly 39% of adults around the world are overweight, and 13% have obesity. In the United States alone, more than 2 in 5 adults are affected by obesity and nearly 1 in 3 are overweight. The obesity epidemic has serious consequences for public health, as obesity and overweight are associated with an increased risk for diabetes, stroke, heart disease, and certain cancers.

What Should You Know About Dementia?

Dementia affects more than 55 million people around the world. It is an important cause of death and disability among older adults, and its global cost reaches 1.3 trillion U.S. dollars annually.

System advisory re the Crowdstrike computer outage